

"Decentralising healthcare through beneficial Artificial Superintelligence"
Oxford Immune Algorithmics applies Artificial Superintelligence to transform disease detection and prevention. The company develops Algocyte, a remote blood monitoring platform combining clinical data with predictive intelligence to identify health transitions before they become critical. Incubated by Oxford, Cambridge, and King's College London, it addresses antibiotic resistance, chronic inflammation, and cancer. The technology enables early intervention through portable, automated diagnostics. With access to 18 million clinical records and 125 million blood test results, Oxford Immune Algorithmics delivers precision risk scores and personalised baselines that shift healthcare from reactive treatment to proactive prevention.


38
Team Members
2018
Founded
Digital Health
Sector
Remote
Work Environment
A world where everyone, everywhere has equal access to the highest quality healthcare, where disease is detected before symptoms appear, and where sick care transforms into genuine health care through intelligent prevention.
At Oxford Immune Algorithmics, our mission is to solve disease by understanding how individuals transition from health to disease, enabling early intervention through super early disease detection and preventive medicine.